RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
This is great! Highly recommend everyone check out this territorial regarding when to use/stop/ continue PPIs!
RT @BrianSecemskyMD: Excellent brief case of the harms of overstating risks and de-prescribing medications (e.g. here PPI) when indicated a…
RT @BrianSecemskyMD: Excellent brief case of the harms of overstating risks and de-prescribing medications (e.g. here PPI) when indicated a…
Tanto uso excesivo como infrautilización de #IBP conlleva riesgos. Importancia de selección adecuada de pacientes: ❗ múltiples factores de riesgo de úlcera péptica ⛔ si no indicación de uso prolongado (ej dispepsia) involucrar a pacientes en decisiones htt
RT @RaymondYYeow: Former @UM_IntMedCMRs and current @UMichGIHep Fellow @Kevin_D_Platt thoughtfully outlining considerations before disconti…
Check out this helpful guide for PPI discontinuation by my rock star co-fellow 💩⭐️ @Kevin_D_Platt @UMichGIHep
RT @RaymondYYeow: Former @UM_IntMedCMRs and current @UMichGIHep Fellow @Kevin_D_Platt thoughtfully outlining considerations before disconti…
RT @RaymondYYeow: Former @UM_IntMedCMRs and current @UMichGIHep Fellow @Kevin_D_Platt thoughtfully outlining considerations before disconti…
RT @UM_IntMedCMRs: Fantastic job, @Kevin_D_Platt, @SameerDSaini, @jekurlander! Definitely an important topic that is not discuss as often a…
RT @UM_IntMedCMRs: Fantastic job, @Kevin_D_Platt, @SameerDSaini, @jekurlander! Definitely an important topic that is not discuss as often a…
One week into fellowship and my man @Kevin_D_Platt is already churning out JAMA publications
Fantastic job, @Kevin_D_Platt, @SameerDSaini, @jekurlander! Definitely an important topic that is not discuss as often as we’d like. Many times PPIs are discontinued without much discussion or consideration for risk/benefit long-term. Important to always i
Former @UM_IntMedCMRs and current @UMichGIHep Fellow @Kevin_D_Platt thoughtfully outlining considerations before discontinuing PPIs. Risk factors for UGIB must be first considered and modifiable risk factors addressed! Great work! 👏🏼#GoBlue 〽️ https://t.c
Seleccionando pacientes para tratamiento discontinuo con inhibidores de la bomba de protones https://t.co/cv9anu7Ips
Rational use of PPI
RT @FrankMoriarty: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation: A Teachable Moment https://t.co/z6n7R2EbQk…
RT @FrankMoriarty: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation: A Teachable Moment https://t.co/z6n7R2EbQk…
Just like when prescribing you need to engage brain and consider risks v benefits before de-prescribing https://t.co/sx9j1SeqMN
RT @FrankMoriarty: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation: A Teachable Moment https://t.co/z6n7R2EbQk…
Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation: A Teachable Moment https://t.co/z6n7R2EbQk Key message: "Both inappropriate overuse and underuse of PPIs carry their own risks of preventable harm."
RT @Sefap_FAP: (JAMA) Selección de los pacientes apropiados para la interrupción del inhibidor de la bomba de protones https://t.co/Jz9wOC…
RT @Sefap_FAP: (JAMA) Selección de los pacientes apropiados para la interrupción del inhibidor de la bomba de protones https://t.co/Jz9wOC…
(JAMA) Selección de los pacientes apropiados para la interrupción del inhibidor de la bomba de protones https://t.co/Jz9wOCxbq3
Excellent brief case of the harms of overstating risks and de-prescribing medications (e.g. here PPI) when indicated and/or benefits clearly outweigh risks. Bravo @JAMAInternalMed https://t.co/eM38V2kZ6i
#Deprescribing is good... when you pick the drugs that the patient doesn't really need! Case report of pt (also on NSAID & aspirin) whose PPI was stopped then had a GI bleed: https://t.co/k3msG0sM4G Engage brain before engaging fingers... https://t.co
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @RitikaParris: when #deprescribing and providing #highvaluecare, PPIs are often low hanging fruit to discontinue. This @JAMAInternalMed…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @PabloGeriatria: Seleccionando de forma apropiada a los pacientes para discontinuación de IBP. Interesante a mi parecer: edad de 70-79…
RT @RitikaParris: when #deprescribing and providing #highvaluecare, PPIs are often low hanging fruit to discontinue. This @JAMAInternalMed…
when #deprescribing and providing #highvaluecare, PPIs are often low hanging fruit to discontinue. This @JAMAInternalMed #teachablemomemt highlights RFs for GIB and when to consider KEEPING the PPI, which then become #highvaluecare. https://t.co/wqNLtICMA
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
RT @rincondesisifo: (JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o caracterís…
(JAMA Intern Med) Factores de riesgo de hemorragia gastrointestinal asociados al tratamiento farmacológico o características del paciente https://t.co/31YGHhj6gX Revisión https://t.co/wkEF6g9dsP
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @SBurtey: Must read teachable moment about PPI discontinuation. A lire parfois arrêter les IPP n'est pas une bonne idée. Le tableau avec…
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @farmaciaclinico: Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation #desprescripcion https://t.co/6WVpDuizIV
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
Seleccionando de forma apropiada a los pacientes para discontinuación de IBP. Interesante a mi parecer: edad de 70-79 años =riesgo relativo de 4.5, por otro lado todos los efectos que trae aparejado el uso de IBP`s .osteoprosis, clostridium, neumonia... h
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @SBurtey: Must read teachable moment about PPI discontinuation. A lire parfois arrêter les IPP n'est pas une bonne idée. Le tableau avec…
RT @SBurtey: Must read teachable moment about PPI discontinuation. A lire parfois arrêter les IPP n'est pas une bonne idée. Le tableau avec…
RT @brzoskos: Very good read in @JAMANetwork , the reasonable voice on #PPI issue in the era of the contemporary status of evidence with no…
Must read teachable moment about PPI discontinuation. A lire parfois arrêter les IPP n'est pas une bonne idée. Le tableau avec le risque de saignements digestifs est priceless. https://t.co/0VUTiSGH1a
Very good read in @JAMANetwork , the reasonable voice on #PPI issue in the era of the contemporary status of evidence with not so rare case example https://t.co/6AUICxLKbH
Selecting the Appropriate Patients for Proton Pump Inhibitor Discontinuation. On top of these arguments comes the risk of nutritional deficiencies like those of vitamin B12 and magnesium. https://t.co/mCy7yeJltf
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
RT @lizabmn47: JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation…
JAMA IM Teachable Moments Tweetorial #3: Selecting the Appropriate Patients for Proton Pump Inhibitor (PPI) Discontinuation by Drs. @Kevin_D_Platt @SameerDSaini @jekurlander! @UMichGIHep @UM_IntMedCMRs@JAMAInternalMed #highvaluecare #tweetorial https://t.c